ReviewWorld journal of gastroenterology2015
Incidence and treatment of brain metastasis in patients with esophageal carcinoma.
Review in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 22 citations in OpenAlex.
- Incidence and prognosis of brain metastases in esophageal carcinoma: a systematic review and meta-analysis.Journal of thoracic disease · 2025Article
- Could intracranial tumor volume predict prognosis of patients with brain metastases from esophageal carcinoma?Thoracic cancer · 2022Article
- Midlife brain metastases in the United States: Is male at risk?Cancer medicine · 2022Article
- The benefit of bevacizumab therapy in patients with refractory vasogenic edema caused by brain metastasis from lung and colon cancers.Frontiers in oncology · 2022Article
- Case Report: Immune Checkpoint Inhibitors Successfully Controlled Asymptomatic Brain Metastasis in Esophageal Squamous Cell Carcinoma.Frontiers in immunology · 2022Article
- The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type.BMC cancer · 2021Article
- Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis.Frontiers in oncology · 2021Article
- Prognostic factors affecting long-term outcomes in patients with brain metastasis from esophageal carcinoma.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2020Article
- Association of Immunotherapy With Survival Among Patients With Brain Metastases Whose Cancer Was Managed With Definitive Surgery of the Primary Tumor.JAMA network open · 2020Article
- Long term results of different radiotherapy techniques and fractions for esophageal squamous cell carcinoma.Translational cancer research · 2020Article
- Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain.The Annals of thoracic surgery · 2020Article
- Review
- Long-term survival after multidisciplinary therapy for brain metastases from asymptomatic esophageal adenocarcinoma.Clinical journal of gastroenterology · 2018Article
- Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study.Journal of neuro-oncology · 2017Article
- Outcomes in patients with brain metastasis from esophageal carcinoma.Journal of gastrointestinal oncology · 2016Article
- Effect of miR-503 Down-Regulation on Growth and Invasion of Esophagus Carcinoma and Related Immune Function.Medical science monitor : international medical journal of experimental and clinical research · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain metastasis from esophageal carcinoma (BMEC) is very rare, but its incidence has increased in the United States, Japan, China and other counties. Reports on BMEC have largely been focused on examining whether adjuvant therapy for esophageal cancer influences the survival duration of BMEC patients and on the imaging characteristics of BMEC determined using new medical equipment. The difference between different pathological types of esophageal cancer, especially adenocarcinoma and squamous cell carcinoma, is one important factor used to assess the influence of BMEC. Adjuvant therapy, including radiotherapy and chemotherapy, for esophageal cancer with different characteristics in different countries may affect BMEC treatment outcomes. The degree of popularization of advanced medical equipment is a major concern related to the prevalence of BMEC. Furthermore, targeted BMEC treatment is under development in developed countries. In this article, we reviewed the debate surrounding BMEC and analyzed BMEC studies from different perspectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.